PATIENCE NYINDEM: Open Payments
NPI 1588301402 · ARGYLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 21 payments from 8 companies in 2025. Trend: 2023 $339 · 2024 $223 · 2025 $601
Food & beverage: $574Education: $27
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $248 |
| Braeburn Inc. | 1 | $124 |
| Corium, LLC | 5 | $84 |
| Alkermes, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: COBENFY, BRIXADI, Azstarys, ARISTADA, Auvelity, TRINTELLIX, CAPLYTA, SPRAVATO.
Industry payments across TX — which companies pay providers there.
